This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2015 Jan;22(1):16-27.

doi: 10.1007/s12282-014-0555-x. Epub 2014 Aug 2.

The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer

Naruto Taira¹, Masami Arai, Masahiko Ikeda, Motoki Iwasaki, Hitoshi Okamura, Kiyoshi Takamatsu, Seiichiro Yamamoto, Shozo Ohsumi, Hirofumi Mukai; Japanese Breast Cancer Society

Affiliations

PMID: 25085807
DOI: 10.1007/s12282-014-0555-x

Practice Guideline

The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer

Naruto Taira et al. Breast Cancer. 2015 Jan.

. 2015 Jan;22(1):16-27.

doi: 10.1007/s12282-014-0555-x. Epub 2014 Aug 2.

Authors

Naruto Taira¹, Masami Arai, Masahiko Ikeda, Motoki Iwasaki, Hitoshi Okamura, Kiyoshi Takamatsu, Seiichiro Yamamoto, Shozo Ohsumi, Hirofumi Mukai; Japanese Breast Cancer Society

Affiliation

¹ Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan, ntaira@md.okayama-u.ac.jp.

PMID: 25085807
DOI: 10.1007/s12282-014-0555-x

No abstract available

PubMed Disclaimer

Similar articles

Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
Hirasawa A, Masuda K, Akahane T, Tsuruta T, Banno K, Makita K, Susumu N, Jinno H, Kitagawa Y, Sugano K, Kosaki K, Aoki D. Hirasawa A, et al. Jpn J Clin Oncol. 2013 May;43(5):515-9. doi: 10.1093/jjco/hyt036. Epub 2013 Mar 13. Jpn J Clin Oncol. 2013. PMID: 23487443
Breast & ovarian cancer. Issues in risk assessment.
Caro SW. Caro SW. Adv Nurse Pract. 1999 Aug;7(8):26-32; quiz 33-4. Adv Nurse Pract. 1999. PMID: 10745719 Review. No abstract available.
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP. Shulman LP. Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Obstet Gynecol Clin North Am. 2010. PMID: 20494261 Review.
[Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].
Singer CF, Tea MK, Pristauz G, Hubalek M, Rappaport C, Riedl C, Helbich T. Singer CF, et al. Wien Klin Wochenschr. 2012 May;124(9-10):334-9. doi: 10.1007/s00508-012-0173-6. Epub 2012 May 28. Wien Klin Wochenschr. 2012. PMID: 22644217 German.
[Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
Radulović S, Branković-Magić M, Janković R, Ristanović M. Radulović S, et al. Srp Arh Celok Lek. 2003 Jul-Aug;131(7-8):345-50. Srp Arh Celok Lek. 2003. PMID: 14692152 Review. Serbian.

See all similar articles

Cited by

MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer.
Yang JY, Sun YW, Liu DJ, Zhang JF, Li J, Hua R. Yang JY, et al. Am J Cancer Res. 2014 Nov 19;4(6):663-73. eCollection 2014. Am J Cancer Res. 2014. PMID: 25520858 Free PMC article.
Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan.
Tozaki M, Nakamura S, Kitagawa D, Iwase T, Horii R, Akiyama F, Arai M. Tozaki M, et al. Magn Reson Med Sci. 2017 Jul 10;16(3):265-269. doi: 10.2463/mrms.cr.2016-0090. Epub 2017 Jan 13. Magn Reson Med Sci. 2017. PMID: 28090007 Free PMC article.
Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women.
Guo J, Sueta A, Nakamura K, Yoshimoto N, Baba M, Ishida N, Hagio K, Toyama T, Iwase H, Tamakoshi A, Yamashita H. Guo J, et al. Oncotarget. 2017 Aug 11;8(39):65759-65769. doi: 10.18632/oncotarget.20182. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029469 Free PMC article.
miR-216 Is a Key Regulator and Potential Marker in Human Cancers.
Mondeali M, Mozaffari F, Ghiasizadeh P, Bakhti S, Salehi M, Kamali N, Rafat M. Mondeali M, et al. Adv Biomed Res. 2025 May 31;14:40. doi: 10.4103/abr.abr_184_23. eCollection 2025. Adv Biomed Res. 2025. PMID: 40519574 Free PMC article. Review.
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition.
Kawai M, Ohtani S, Iwasaki M, Yamamoto S, Takamatsu K, Okamura H, Arai M, Nomura T, Ozaki S, Shibata KI, Akabane A, Motoi F, Yamauchi C, Yamamoto Y, Iwata H, Saji S. Kawai M, et al. Breast Cancer. 2024 Mar;31(2):166-178. doi: 10.1007/s12282-023-01531-9. Epub 2023 Dec 26. Breast Cancer. 2024. PMID: 38147174 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information